Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (481-490 of 554) with videos related to

Pageof 56
Sort By:
Science Translational Medicine|June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's diseaseAura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Science Translational Medicine|April 21, 2017
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathyKiran Yanamandra, Tirth K Patel, Hong Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 5, 2026
APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseFuhai Li, Yike Chen, Daniel Western, et al.
Cell|June 24, 2022
Cholesterol and matrisome pathways dysregulated in astrocytes and microgliaJulia Tcw, Lu Qian, Nina H Pipalia, et al.
Molecular Neurodegeneration|February 16, 2024
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific mannerMegan E Bosch, Hemraj B Dodiya, Julia Michalkiewicz, et al.
Science Translational Medicine|April 29, 2026
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological diseaseDaniel Western, Chengran Yang, Jigyasha Timsina, et al.
Science Translational Medicine|March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's diseaseAnne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving declineCatherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Nature Communications|July 2, 2024
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individualsChengjie Xiong, Jingqin Luo, David A Wolk, et al.
Brain Communications|March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's diseaseKarin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.
Pageof 56

Showing results (481-490 of 554) with videos related to

Sort By:
Pageof 56
Science Translational Medicine|June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's diseaseAura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Science Translational Medicine|April 21, 2017
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathyKiran Yanamandra, Tirth K Patel, Hong Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 5, 2026
APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseFuhai Li, Yike Chen, Daniel Western, et al.
Cell|June 24, 2022
Cholesterol and matrisome pathways dysregulated in astrocytes and microgliaJulia Tcw, Lu Qian, Nina H Pipalia, et al.
Molecular Neurodegeneration|February 16, 2024
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific mannerMegan E Bosch, Hemraj B Dodiya, Julia Michalkiewicz, et al.
Science Translational Medicine|April 29, 2026
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological diseaseDaniel Western, Chengran Yang, Jigyasha Timsina, et al.
Science Translational Medicine|March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's diseaseAnne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving declineCatherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Nature Communications|July 2, 2024
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individualsChengjie Xiong, Jingqin Luo, David A Wolk, et al.
Brain Communications|March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's diseaseKarin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.
Pageof 56